The vaccine safety datalink: A model for monitoring immunization safety

Pediatrics

Volumn 127, Issue SUPPL. 1, 2011, Pages

  Baggs, James ^a   Gee, Julianne ^a   Lewis, Edwin ^b   Fowler, Gabrielle ^a   Benson, Patti ^c   Lieu, Tracy ^d   Naleway, Allison ^b   Klein, Nicola P ^b   Baxter, Roger ^b   Belongia, Edward ^e   Glanz, Jason ^b   Hambidge, Simon J ^b,f   Jacobsen, Steven J ^b   Jackson, Lisa ^c   Nordin, Jim ^g   Weintraub, Eric ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KAISER PERMANENTE   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MARSHFIELD CLINIC   (United States)

^f DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^g HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

Immunization; Postmarketing evaluation; Surveillance; Vaccine safety; Vaccine safety datalink

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ROTAVIRUS VACCINE; THIOMERSAL; VACCINE; WART VIRUS VACCINE;

CHICKENPOX; DIPHTHERIA; DRUG SAFETY; DUODENITIS; EMERGENCY CARE; GASTRITIS; GUILLAIN BARRE SYNDROME; HEPATITIS B; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFLUENZA; INFORMATION PROCESSING; INFORMATION RETRIEVAL; INTUSSUSCEPTION; MANAGED CARE ORGANIZATION; MEASLES; MEDICAL INFORMATION; MENINGOCOCCOSIS; MORTALITY; MUMPS; OUTPATIENT CARE; PAPILLOMAVIRUS INFECTION; PERTUSSIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS INFECTION; RUBELLA; TETANUS; UNITED STATES; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DATABASE MANAGEMENT SYSTEMS; DRUG TOXICITY; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; MONITORING, IMMUNOLOGIC; PRODUCT SURVEILLANCE, POSTMARKETING; SAFETY MANAGEMENT; UNITED STATES; VACCINES;

EID: 79952474136     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1722H     Document Type: Review

References (62)

1. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155-2163 (Pubitemid 350106654)
2. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children: United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 1999;48(12):243-248
3. Chen RT, Mootrey G, DeStefano F. Safety of routine childhood vaccinations: an epidemiological review. Paediatr Drugs. 2000;2(4):273-290 (Pubitemid 30625805)
4. Bohlke K, Davis RL, Marcy SM, et al; Vaccine Safety Datalink Team. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112(4):815-820
5. Cooper LZ, Larson HJ, Katz SL. Protecting public trust in immunization. Pediatrics. 2008;122(1):149-153
6. Chen RT, DeStefano F, Davis RL, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ. 2000;78(2):186-194 (Pubitemid 30151603)
7. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406
8. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics. 1997;99(6):765-773
9. Wassilak SG, Glasser JW, Chen RT, Hadler SC. Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann N Y Acad Sci. 1995;754:377-382
10. Baggs J, Lewis E, Amundson JH, et al. Distributed data models for the Vaccine Safety Datalink (VSD). Presented at: 10th Annual HMO Research Network Conference. May 5, 2004; Dearborn, MI
11. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996;143(11):1165-1173 (Pubitemid 26158114)
12. Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine. 2004;22(15-16):2064-2070 (Pubitemid 38581081)
13. Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology. 2005;16(3):336-341 (Pubitemid 40590071)
14. Lieu TA, Kulldorff M, Davis RL, et al; Vaccine Safety Datalink Rapid Cycle Analysis Team. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 suppl 2):S89-S95
15. Varricchio F, Iskander J, DeStefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004;23(4):287-294 (Pubitemid 38508877)
16. Centers for Disease Control and Prevention. Postmarketing monitoring of intussusception after RotaTeq vaccination: United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep. 2007;56(10):218-222
17. Centers for Disease Control and Prevention. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June 2005-September 2006 [published correction appears in MMWR Morb Mortal Wkly Rep. 2006;55(43):1177]. MMWR Morb Mortal Wkly Rep. 2006;55(41):1120-1124
18. Centers for Disease Control and Prevention. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine - United States, October 2005-February 2006. MMWR Morb Mortal Wkly Rep. 2006;55(13):364-366
19. Thompson WW, Price C, Goodson B, et al; Vaccine Safety Datalink Team. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357(13):1281-1292 (Pubitemid 47481450)
20. Yu O, Bohlke K, Hanson CA, et al. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2007;16(7):736-745 (Pubitemid 47180363)
21. Hambidge SJ, Glanz JM, France EK, et al; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296(16):1990-1997
22. Centers for Disease Control and Prevention. Recommendations regarding the use of vaccines that contain thimerosal as a preservative. MMWR Morb Mortal Wkly Rep. 1999;48(43):996-998
23. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics. 2004;114(3):584-591 (Pubitemid 41529510)
24. DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther. 2007;82(6):756-759 (Pubitemid 350114826)
25. Heron J, Golding J; ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association. Pediatrics. 2004;114(3):577-583 (Pubitemid 41529509)
26. Madsen KM, Lauritsen MB, Pedersen CB, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics. 2003;112(3 pt 1):604-606 (Pubitemid 37082114)
27. Meadows M. IOM report: no link between vaccines and autism. FDA Consum. 2004;38(5):18-19
28. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data [published correction appears in Pediatrics. 2005;115(1):200]. Pediatrics. 2004;114(3):793-804
29. Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med. 2003;25(2):101-106 (Pubitemid 36918347)
30. Taylor B. Vaccines and the changing epidemiology of autism. Child Care Health Dev. 2006;32(5):511-519 (Pubitemid 44210089)
31. Verstraeten T, Davis RL, DeStefano F, et al; Vaccine Safety Datalink Team. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases [published correction appears in Pediatrics. 2004;113(1):184]. Pediatrics. 2003;112(5):1039-1048
32. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121(6):1206-1212
33. Belongia E, Irving S, Shui I, et al. Rapid cycle analysis of pentavalent rotavirus (RotaTeq) vaccine safety in the Vaccine Safety Datalink population: preliminary results. Presented at: Advisory Committee on Immunization Practices meeting; June 25, 2008; Atlanta, GA
34. Irving SA, Belongia EA, Shui IM, et al. Rapid cycle analysis of pentavalent rotavirus vaccine safety in the Vaccine Safety Datalink Population. Presented at: the joint 46th Annual Infectious Diseases Society of America Conference and 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. October 25, 2008; Washington, DC
35. Klein N. Vaccine Safety Datalink project: evaluation of MMRV and febrile seizures. Presented at: Advisory Committee on Immunization Practices February 2008 meeting; February 27, 2008; Atlanta, GA
36. Glanz JM, McClure DL, Xu S, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59(8):808-818 (Pubitemid 43996937)
37. Centers for Disease Control and Prevention. Rapid assessment of influenza vaccination coverage among HMO members: northern California influenza seasons, 2001-02 through 2004-05. MMWR Morb Mortal Wkly Rep. 2005;54(27):676-678
38. Jackson LA, Neuzil KM, Baggs J, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics. 2006;118(5):2032-2037 (Pubitemid 46393686)
39. Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule: United States, February 2006-May 2007. MMWR Morb Mortal Wkly Rep. 2008;57(15):398-401
40. Lin ND, Kleinman K, Chan KA, et al; Vaccine Safety Datalink Team. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatr. 2006;6:31
41. Lin ND, Kleinman K, Chan KA, et al; Vaccine Safety Datalink Group. Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants. BMC Pediatr. 2005;5:43
42. Belay ED, Holman RC, Clarke MJ, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J. 2000;19(9):828-832
43. Parashar UD, Holman RC, Bresee JS, et al. Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team. Pediatr Infect Dis J. 1998; 17(7):605-611
44. Averhoff F, Zucker J, Vellozzi C, et al. Adequacy of surveillance to detect endemic rubella transmission in the United States. Clin Infect Dis. 2006;43(suppl 3):S151-S157 (Pubitemid 44632792)
45. Mullooly JP, Bridges CB, Thompson WW, et al; Vaccine Safety Datalink Adult Working Group. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25(5):846-855
46. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. 2004;113(3):536-542 (Pubitemid 38338961)
47. Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133(2):245-253
48. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239 (Pubitemid 30058954)
49. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004;113(3 pt 1):585-593 (Pubitemid 38280802)
50. McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008;26(26):3341-3345
51. Lieu TA, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG. The hidden costs of infant vaccination. Vaccine. 2000;19(1):33-41 (Pubitemid 30618952)
52. Prosser LA, Bridges CB, Uyeki TM, et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005;3:18
53. Prosser LA, Bridges CB, Uyeki TM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548-1558 (Pubitemid 44570897)
54. Hinrichsen VL, Kruskal B, O'Brien MA, Lieu TA, Platt R. Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Inform Assoc. 2007;14(6):731-735 (Pubitemid 350030894)
55. Mullooly J, Drew L, DeStefano F, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety Datalink Team. Am J Epidemiol. 1999;149(2):186-194 (Pubitemid 29039522)
56. Mullooly J, Drew L, DeStefano F, et al. Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety. Methods Inf Med. 2004;43(2):163-170 (Pubitemid 38720402)
57. Davila JC, Payne DC, Zhang Y, et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004. Vaccine. 2008;26(12):1577-1584
58. Payne DC, Rose CE Jr, Aranas A, et al. Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Pharmacoepidemiol Drug Saf. 2007;16(6):605-611
59. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92(12):1900-1904 (Pubitemid 35386611)
60. Wong IC, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol. 2005;59(6):750-755 (Pubitemid 40838627)
61. Hviid A. Postlicensure epidemiology of childhood vaccination: the Danish experience. Expert Rev Vaccines. 2006;5(5):641-649 (Pubitemid 46021046)
62. Ali M, Canh GD, Clemens JD, et al; Vaccine Safety Datalink Group. The use of a computerized database to monitor vaccine safety in Viet Nam. Bull World Health Organ. 2005;83(8):604-610